Sign inGet started

HERLIHY WALTER C

Insider CIK 1241029 · RGEN PRESIDENT, CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RGEN REPLIGEN CORP S Sale2015-05-122015-05-1445,431$38.97 $1.77M262,430SEC↗
RGEN REPLIGEN CORP S Sale2015-05-112015-05-1235,715$38.68 $1.38M317,861SEC↗
RGEN REPLIGEN CORP G Gift2015-05-112015-05-1210,000— $0307,861SEC↗
RGEN REPLIGEN CORP S Sale2015-05-082015-05-1268,854$37.55 $2.59M353,576SEC↗
RGEN REPLIGEN CORP S Sale2015-03-232015-03-2323,686$31.76 $752.3K422,430SEC↗
RGEN REPLIGEN CORP S Sale2015-03-202015-03-23850$32.51 $27.6K446,116SEC↗
RGEN REPLIGEN CORP S Sale2015-03-192015-03-2049,695$33.08 $1.64M446,966SEC↗
RGEN REPLIGEN CORP S Sale2014-11-192014-11-204,158$22.95 $95.4K496,661SEC↗
RGEN REPLIGEN CORP S Sale2014-11-182014-11-2047,228$23.47 $1.11M500,819SEC↗
RGEN REPLIGEN CORP M Exercise deriv2014-11-142014-11-1810,000— $010,000SEC↗
RGEN REPLIGEN CORP M Exercise2014-11-142014-11-1810,000$3.33 $33.3K549,477SEC↗
RGEN REPLIGEN CORP F Tax w/h2014-11-142014-11-181,430$23.30 $33.3K548,047SEC↗
RGEN REPLIGEN CORP S Sale2014-06-112014-06-1260,335$20.11 $1.21M539,477SEC↗
RGEN REPLIGEN CORP M Exercise deriv2014-06-062014-06-1021,250— $063,750SEC↗
RGEN REPLIGEN CORP M Exercise deriv2014-06-062014-06-1010,000— $020,000SEC↗
RGEN REPLIGEN CORP M Exercise deriv2014-06-062014-06-1020,000— $00SEC↗
RGEN REPLIGEN CORP F Tax w/h2014-06-062014-06-105,752$20.41 $117.4K576,680SEC↗
RGEN REPLIGEN CORP F Tax w/h2014-06-062014-06-106,486$20.41 $132.4K599,812SEC↗
RGEN REPLIGEN CORP M Exercise2014-06-062014-06-1021,250$6.23 $132.4K606,298SEC↗
RGEN REPLIGEN CORP F Tax w/h2014-06-062014-06-101,632$20.41 $33.3K585,048SEC↗
RGEN REPLIGEN CORP M Exercise2014-06-062014-06-1020,000$5.87 $117.4K582,432SEC↗
RGEN REPLIGEN CORP M Exercise2014-06-062014-06-1010,000$3.33 $33.3K586,680SEC↗
RGEN REPLIGEN CORP A Award deriv2014-02-272014-03-0347,200— $047,200SEC↗
RGEN REPLIGEN CORP A Award2014-02-272014-03-0324,639— $0562,432SEC↗
RGEN REPLIGEN CORP S Sale2013-05-152013-05-161,514$8.85 $13.4K537,793SEC↗
RGEN REPLIGEN CORP G Gift2013-05-142013-05-1610,000— $0539,307SEC↗
RGEN REPLIGEN CORP S Sale2013-05-142013-05-1638,486$8.98 $345.6K549,307SEC↗
RGEN REPLIGEN CORP M Exercise deriv2013-05-032013-05-0620,000— $0135,000SEC↗
RGEN REPLIGEN CORP M Exercise deriv2013-05-032013-05-0680,000— $0155,000SEC↗
RGEN REPLIGEN CORP M Exercise deriv2013-05-032013-05-0650,000— $0235,000SEC↗
RGEN REPLIGEN CORP F Tax w/h2013-05-032013-05-067,458$8.93 $66.6K587,793SEC↗
RGEN REPLIGEN CORP F Tax w/h2013-05-032013-05-0617,078$8.93 $152.5K547,838SEC↗
RGEN REPLIGEN CORP M Exercise2013-05-032013-05-0680,000$5.87 $469.6K627,838SEC↗
RGEN REPLIGEN CORP F Tax w/h2013-05-032013-05-0652,587$8.93 $469.6K575,251SEC↗
RGEN REPLIGEN CORP M Exercise2013-05-032013-05-0620,000$3.33 $66.6K595,251SEC↗
RGEN REPLIGEN CORP M Exercise2013-05-032013-05-0650,000$3.05 $152.5K564,916SEC↗
RGEN REPLIGEN CORP M Exercise deriv2013-03-262013-03-2765,000— $0285,000SEC↗
RGEN REPLIGEN CORP F Tax w/h2013-03-262013-03-2751,982$6.89 $358.2K514,916SEC↗
RGEN REPLIGEN CORP M Exercise2013-03-262013-03-2765,000$5.51 $358.1K566,898SEC↗
RGEN REPLIGEN CORP A Award deriv2013-02-282013-03-1285,000— $0350,000SEC↗
RGEN REPLIGEN CORP M Exercise deriv2012-03-272012-03-2850,000— $0265,000SEC↗
RGEN REPLIGEN CORP M Exercise2012-03-272012-03-2850,000$1.83 $91.5K518,938SEC↗
RGEN REPLIGEN CORP F Tax w/h2012-03-272012-03-2817,040$5.37 $91.5K501,898SEC↗
RGEN REPLIGEN CORP M Exercise deriv2012-03-152012-03-1950,000— $0315,000SEC↗
RGEN REPLIGEN CORP F Tax w/h2012-03-152012-03-1933,265$4.87 $162.0K468,938SEC↗
RGEN REPLIGEN CORP M Exercise2012-03-152012-03-1950,000$3.24 $162.0K502,203SEC↗